Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei.
Sign Up to like & getrecommendations! Published in 2019 at "Clinical colorectal cancer"
DOI: 10.1016/j.clcc.2019.03.002
Abstract: BACKGROUND No standard treatment for advanced unresectable pseudomyxoma peritonei (PMP) has been defined so far. PMP is traditionally considered chemoresistant but nonrandomized series showed promising results with regimens for gastrointestinal tumors. PATIENTS AND METHODS We… read more here.
Keywords: metronomic capecitabine; capecitabine cyclophosphamide; regimen unresectable; pseudomyxoma peritonei ... See more keywords